Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

RFI – Enhanced Maritime Biological Detection (EMBD)

by Global Biodefense Staff
August 29, 2017
Biodefense RFI Market Research

The Enhanced Maritime Biological Detection (EMBD) program is charged with finalizing development, and complete testing, integration and production of an automated biological warfare agent point detection system.

The EMBD program has issued a Special Notice to receive feedback from industry regarding a Draft Performance Work Statement (PWS) for the planned technology upgrade to the existing Joint Biological Point Detection System (JBPDS).

The U.S. Navy will integrate an EMBD retrofit kit into a fielded JBPDS. The contractor will build upon the upgrade efforts completed under the JBPDS production contract, utilizing five Line Replaceable Units (LRUs) that perform the following core biological defense functions:

  • Detection (Rapid Agent Aerosol Detector (RAAD))
  • Collection (Wetted Wall Cyclone (WWC) Collector)
  • Identification (Lateral Flow Immunoassay Identifier)
  • Sample Handling (Fluid Transfer System (FTS))
  • Local User Interface (Computing and Control Subsystem (CCS))

The LRUs are integrated into the Biosuite Enclosure (BSE) and receive conditioned power from the Power Pack. EMBD can be controlled locally by the CCS and remotely by the External Controller Subsystem (ECS).

The objective of the EMBD acquisition is to develop and produce EMBD systems for Engineering and Manufacturing Development (EMD), First Article Testing, Logistics and Government Testing. As part of EMD, the Government will provide 10 legacy JBPDS units to the Contractor and the Contractor will be responsible to convert each into an EMBD system.

Requirements include EMD engineering, development and manufacture of hardware, support of Government program, testing and logistics efforts and delivery of technical data. The EMBD acquisition also includes options for Low Rate Initial Production (LRIP) and Full Rate Production (FRP) of EMBD retrofit kits.

Further details are available via Solicitation Number: EMBD_PWS. The response deadline is Sep 11, 2017 4:00 pm Eastern.

Related: DoD Seeks to Enhance Navy’s Biological Warfare Agent Identification Systems (May 2017)

Tags: JPEO-CBRNDRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC